National Cancer Centre Singapore selects RayStation for new proton center
RaySearch Laboratories AB (publ) announces that the National Cancer Centre Singapore (NCCS) has placed an order for RayStation[®*] as the treatment planning system for its new proton therapy center currently under construction and scheduled for completion by 2022.NCCS provides a holistic, multi-disciplinary approach to cancer treatment and patient care, and sees close to 65 percent of Singapore’s public sector oncology cases.
The Goh Cheng Liang Proton Therapy Centre at NCCS will be equipped with the state-of-the-art PROBEAT treatment delivery system from Hitachi. The setup will include